tirzepatide po FDA Grants a New Indication for Obesity Management Zepbound (Tirzepatide): A Q&A on

Both medications work best as part of a long-term weight-management plan

Zepbound (tirzepatide) is an FDA-approved medication for chronic weight management that works by reducing appetite through dual GIP and GLP-1 receptor activation

This consistency is one reason why standardized dosing guides work reliably across diverse patient populations

This means your dose may need to go up as you progress through your treatment, but your price won't increase

By signaling to the brains appetite control center, the hypothalamus, it helps reduce hunger and food cravings, allowing individuals to consume fewer calories naturally